Samantha J. Pulliam, MD
Chair | Chief Medical Officer at Renovia Inc. | Boston, MA
Prior to Renovia: Assistant Professor and Director, Urogynecology and Reconstructive Pelvic Surgery
University of North Carolina at Chapel Hill | Chapel Hill, NC
Sarah H. Boyles, MD, MPH
Managing Partner, Urogynecology
The Oregon Clinic | Portland, OR
Marianna Alperin, MD
Assistant Professor of Reproductive Medicine, Urogynecology
UC San Diego Health | San Diego, CA
Leslie M. Rickey, MPH, MD
Associate Professor of Urology and of Obstetrics, Gynecology, and Reproductive Sciences
Fellowship Director, Female Pelvic Medicine and Reconstructive Surgery
Yale School of Medicine, Urology | New Haven, CT
Michele R. Hacker, PhD
Associate Professor, Obstetrics Fellowship Director, Female Pelvic Medicine and Reconstructive Surgery
Harvard Medical School | Boston, MA
Associate Professor, Epidemiology
Harvard T.H. Chan School of Public Health | Boston, MA
Vice Chair for Research, Department of Obstetrics and Gynecology
Beth Israel Deaconess Medical Center | Boston, MA
Mickey M. Karram, MD
Dr. Karram is an internationally-renowned urogynecologist and pelvic surgeon. He is board certified in obstetrics and gynecology and completed his fellowship training in urogynecology and reconstructive surgery at Harbor UCLA School of Medicine.
He is currently the Director of Urogynecology and Reconstructive Surgery at The Christ Hospital; medical director of The Christ Hospital Pelvic Floor Center and Clinical Professor of Obstetrics and Gynecology at the University of Cincinnati School of Medicine. He is editor-in-chief of the International Urogynecology Journal and the consumer publication Female Health Today (formerly Women’s Health Today), and is past president of the American Urogynecology Society.
He has published more than 200 scientific articles and book chapters and has co-authored numerous medical textbooks including “Urogynecology and Reconstructive Pelvic Surgery,” published by Mosby, the “Atlas of Pelvic Anatomy and Gynecologic Surgery,” published by Saunders, and “The Pelvic Surgery Video Atlas,” published by Elsevier. Dr. Karram has directed a number of postgraduate teaching courses throughout the United States and abroad. He has been invited to lecture and perform live surgeries throughout the United States, Europe, Asia, South America, and Australia.
Dr. Karram has been designated by Good Housekeeping Magazine as one of the “Best Doctors in America for Women.” Dr. Karram is also co-founder (with his wife Mona) of the national, non-for-profit 50l(c)3 “Foundation for Female Health Awareness,” which raises money to support educational endeavors on women’s health, and also funds much needed, unbiased medical research in gender-specific medicine. For more information, visit www.femalehealthawareness.org
Katherine Klos, MD
Dr. Katherine Klos is a board certified urologist. She is based in Washington, D.C. and specializes in pelvic floor health. Dr. Klos treats conditions ranging from the common recurrent urinary tract infection and incontinence to more complex reconstruction, neuromodulation and chronic pain of the pelvis. Dr. Klos received her Bachelor of Science in Anthropology from the University of Notre Dame and completed her medical degree at the University of Alabama. She completed a rigorous general surgery and urologic residency at George Washington University. Dr. Klos takes a comprehensive and integrative approach to all of her patients in order to achieve the optimum outcomes. She values taking time to establish a trusting and lasting doctor patient relationship. In her free time you can find Dr. Klos spending time outdoors with her husband and three children.
Roger R. Dmochowski, MD, MMHC
Dr. Dmochowski is a Professor at the Department of Urology at Vanderbilt University in Nashville and Director of the Section of Female Pelvic Medicine and supervisor of the Fellowship in Pelvic Medicine at Vanderbilt. He is also Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland and holds additional positions as Vice Chair, Section of Surgical Sciences Vanderbilt University Medical Center, Associate Director of Quality and Safety, Vanderbilt Health System, Executive Director of Risk Prevention for Vanderbilt Health System, Executive Medical Director for Patient Safety and Quality (Surgery),Associate Chief of Staff, and Medical Director of Risk Management at Vanderbilt University Hospital.
Dr. Dmochowski received his medical degree from the University of Texas Medical Branch at Galveston. He completed an internship and residency in surgery and urology at the University of Texas Medical School at Houston and at the M.D. Anderson Hospital and Tumor Institute in Texas. In addition, Dr. Dmochowski is subspecialty fellowship trained in female urology, neurourology, urodynamics and reconstructive urology. He is board certified in urology.
Dr. Dmochowski has published more than 230 articles and 68 book chapters, and 340 abstracts, and has given over 230 presentations at various national and international meetings. He has been featured in videotapes and CD-ROMS on the management of urinary incontinence. Dr. Dmochowski is on the editorial board for the World Journal of Urology, Neurourology and Urodynamics, and International Journal of Urogynecology and the AUA Office of Education CD-ROM Series, and he is a reviewer for the Journal of Urology, and Urology. He is a Fellow of the American College of Surgeons and a member of the American Urological Association and International Continence Society. Dr. Dmochowski has been granted the Zimskind Award from the Urodynamics Society for his accomplishment in clinical treatment for incontinence. His current research interests are outcomes of incontinence therapies with a particular emphasis on quality of life issues. He also is active in bio materials evaluation.
Mark Cone, MD
Mark Cone, MD, is the President of Privia Medical Group – Gulf Coast Texas and has 25 years of experience in private practice.
He is the President of a 53-year-old private practice in Houston, TX, and the President and Chairman of the Board of Directors of Southwest Women’s Health Alliance. He developed and implemented a corporate structure that maximizes a practice’s autonomy and profitability and spearheaded the development and implementation of a first-of-its-kind value-based care program in women’s health for several major payers.
Dr. Cone serves on the Tri-State Advisory Board for Cigna, the HCA Clinical Integration Steering Committee for the Gulf Coast Division, the COEMIG Committee at The Woman’s Hospital of Texas, the Advisory Board for Texas Citizens Bank and is the Chairman of the Advisory Board of Fannin Surgicare ASC. He was responsible for building and deploying new financial reporting standards in the MGMA format that allow individual doctors and care centers to control and reduce operating expenses and maximize their profitability.
Dr. Cone received his medical degree from Baylor College of Medicine, and his bachelor’s degree from Texas A&M.
Catherine A. Matthews, MD
Dr. Catherine A. Matthews is Professor of Female Pelvic Medicine and Reconstructive Pelvic Surgery in the Departments of Ob/Gyn and Urology at Wake Forest University Baptist Health in Winston Salem, North Carolina. She is the Co-Director of a new Integrated Pelvic Health Unit at Wake Forest focusing on the care of women with pelvic floor disorders. Dr. Matthews received her medical degree from the University of Virginia where she served as president of the medical honor society, Alpha Omega Alpha, and graduated Valedictorian of her class. She completed her residency and specialty training in Obstetrics and Gynecology and Urogynecology at Virginia Commonwealth University Medical Center. In 2010, she joined the faculty of the University of North Carolina as Division Chief of Urogynecology where she built a comprehensive pelvic health program.
Voted into “Best doctors in America” since 2006 , she has dedicated her career to improving the quality of life for women who suffer from the potentially embarrassing conditions of urinary and bowel incontinence and pelvic organ prolapse. An avid clinician, teacher, and researcher, her passion is empowering women to address pelvic floor conditions that negatively affect quality of life. Dr. Matthews places special emphasis on patient-centered care including assessment of individual goals and shared medical decision-making. She is nationally and internationally recognized for her expertise in robotic surgery for pelvic floor reconstruction and the repair of complicated genito-urinary fistulae. She also has a particular interest in helping women who sustain perineal trauma during vaginal delivery, including anal sphincter injury, vaginal pain, and rectovaginal fistulae and has established a specialty perineal clinic at Wake Forest Baptist Health to serve these women.
Dr. Matthews is actively involved in research regarding surgical techniques utilizing the Davinci robot, treatment options for accidental bowel leakage, and innovative therapies for stress urinary incontinence. She has received numerous teaching awards and is invited to lecture nationally and internationally on surgical management of pelvic organ prolapse, perineal trauma, and robotic surgery. She is a Board Certified specialist in Female Pelvic Medicine and Reconstructive Surgery.
Jay Cohen, MD
Dr. Jay Steven Cohen, M.D, F.A.C.O.G., serves as Medical Director at Sheridan Clinical Research, Inc. Dr. Cohen has been Medical Director and Principal Investigator for Pharmaceutical Clinical Trials, Sheridan Healthcorp, Inc. since June 1999.
He has over 20 years Investigator experience. Dr. Cohen serves as Member of Board for Experts of eDiets Corporate Services. He served as Sub-Investigator at Peninsular Testing Corp. Phase I/II Studies from 1990 to 2000. Dr. Cohen maintains an extensive practice in South Florida, is a high-profile author and guest lecturer, and was a Clinical Associate Professor in the Department of Obstetrics and Gynecology at the University of Miami School of Medicine/Jackson Memorial Hospital.
He served as a Board Member of the American Cancer Society on its Breast Task Force. Dr. Cohen is the recipient of numerous honors and awards for his practice in medicine. He was mentioned in Miami Magazine as one of South Florida’s ‘Top Docs” as recognized by other physicians 1997-1998. Dr. Cohen was voted one of the “Top Docs in his Field” for years: 2000, 2001, 2002, 2003, 2004 in a National Magazine. He was named in “Best Doctors in America” in 2001-2002, 2005-2006, and 2009-2011. Dr. Cohen received Cambridge Who’s Who, Professional Physicians Honor 2007 & 2008. He received Patient’s Choice Award 2008-2009.
Dr. Cohen is a board certified OB/GYN and diplomat of the American College of Obstetrics. He holds Certification of a Diplomate American College of Obstetrics. Dr. Cohen holds BS in Chemistry from University of Florida, Gainesville, Florida. He graduated from UHS/The Chicago Medical School and served his residency at Jackson Memorial Hospital, where he received the Administrative Chief Resident Award in the department of OB/GYN.
Marc brings more than 25 years of development and commercialization experience in biotechnology, pharmaceuticals, devices, and diagnostics. Marc founded Renovia with Ramon Iglesias, MD and Yolanda Lorié in August 2016 and successfully closed a Series A financing with leading healthcare venture capital funds.
Marc is the former Chief Executive Officer of Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). Aegerion is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Marc took the company public in October 2010. The Company’s first marketed product, JUXTAPID® (lomitapide) was approved by the US Food and Drug Administration in December 2012 for homozygous familial hypercholesterolemia. During his tenure, JUXTAPID obtained marketing approval in 36 countries. Additionally, Aegerion acquired its second product, MYALEPT® (metreleptin), approved in the US for generalized lipodystrophy, an ultra-rare disease.
In April 2000, Marc became the Founding CEO of ViaCell (NASDAQ: VIAC), a biotechnology company specializing in the collection, preservation, and development of umbilical cord blood stem cells, and over a period of seven years led the company from its inception to a rapidly growing and robust commercial organization. Under Marc’s leadership, the company grew to more than 300 employees, went public in 2005 and was ultimately acquired in 2007 by PerkinElmer (NYSE: PKI).
While serving as CEO of ViaCell, Marc also served as a member of the board of directors of Erytech Pharma (NASDAQ: ERYP), a publicly traded biopharmaceutical company. Prior to ViaCell, Marc held various positions within Genzyme, most recently as Vice President of Global Marketing where he was responsible for the commercial launch of several products addressing rare disease populations on a global scale.
Prior to Genzyme, he held a variety of sales and marketing roles in the pharmaceutical and diagnostic divisions of Abbott Laboratories (NYSE: ABT). He also was a former member of the Mass Life Science Board of the Commonwealth of Massachusetts and served on the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board.
Marc was also Founding Chairman of the board of directors and chairman of the compensation committee of Good Start Genetics, Inc., recently acquired by InVitae (NASDAQ: NVTA). He is the Founding Chairman of the board, chairman of the compensation committee and member of the audit committee of Minerva Neurosciences Inc. (NASDAQ: NERV); and a member of the Miami University Business Advisory Council and previously a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council. Marc holds a BS from Miami University (Ohio).